These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25713431)

  • 21. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bisphosphonates in postmenopausal women with breast cancer.
    Gnant M
    Cancer Treat Rev; 2014 Apr; 40(3):476-84. PubMed ID: 23906846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans.
    LaFleur J; DuVall SL; Willson T; Ginter T; Patterson O; Cheng Y; Knippenberg K; Haroldsen C; Adler RA; Curtis JR; Agodoa I; Nelson RE
    Bone; 2015 Sep; 78():174-85. PubMed ID: 25896952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women.
    Olson JE; Sellers TA; Anderson KE; Folsom AR
    Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentional Weight Loss and Endometrial Cancer Risk.
    Luo J; Chlebowski RT; Hendryx M; Rohan T; Wactawski-Wende J; Thomson CA; Felix AS; Chen C; Barrington W; Coday M; Stefanick M; LeBlanc E; Margolis KL
    J Clin Oncol; 2017 Apr; 35(11):1189-1193. PubMed ID: 28165909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F; Borges JL; Curiel MD
    Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perineal powder use and risk of endometrial cancer in postmenopausal women.
    Crawford L; Reeves KW; Luisi N; Balasubramanian R; Sturgeon SR
    Cancer Causes Control; 2012 Oct; 23(10):1673-80. PubMed ID: 22875750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women.
    Patel AV; Feigelson HS; Talbot JT; McCullough ML; Rodriguez C; Patel RC; Thun MJ; Calle EE
    Int J Cancer; 2008 Oct; 123(8):1877-82. PubMed ID: 18651569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is treatment of early postmenopausal women with bisphosphonates justified?
    Epstein S
    Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis for dental implants placed in patients taking oral bisphosphonates.
    Kasai T; Pogrel MA; Hossaini M
    J Calif Dent Assoc; 2009 Jan; 37(1):39-42. PubMed ID: 19263627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.
    Phipps AI; Anderson GL; Cochrane BB; Li CI; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Newcomb PA
    Horm Cancer; 2012 Dec; 3(5-6):240-8. PubMed ID: 22826191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
    De Cock E; Hutton J; Canney P; Body JJ; Barrett-Lee P; Neary MP; Lewis G
    Clin Ther; 2005 Aug; 27(8):1295-310. PubMed ID: 16199254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.
    Fournier A; Mesrine S; Gelot A; Fagherazzi G; Baglietto L; Clavel-Chapelon F; Boutron-Ruault MC; Chabbert-Buffet N
    J Clin Oncol; 2017 Oct; 35(28):3230-3239. PubMed ID: 28708471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    McHorney CA; Schousboe JT; Cline RR; Weiss TW
    Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of treatment benefit due to low compliance with bisphosphonate therapy.
    Penning-van Beest FJ; Erkens JA; Olson M; Herings RM
    Osteoporos Int; 2008 Apr; 19(4):511-7. PubMed ID: 17874028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of bisphosphonates in the management of postmenopausal osteoporosis.
    Papapoulos SE
    Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to oral bisphosphonates and risk of cancer.
    Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
    Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.